301 related articles for article (PubMed ID: 28424818)
21. Idarucizumab (Praxbind)--an antidote for dabigatran.
Med Lett Drugs Ther; 2015 Nov; 57(1482):157-8. PubMed ID: 26583604
[No Abstract] [Full Text] [Related]
22. Idarucizumab for Reversal of Dabigatran: Single-Center Real-World Experience.
Sheikh-Taha M
Am J Cardiovasc Drugs; 2019 Feb; 19(1):59-64. PubMed ID: 30203330
[TBL] [Abstract][Full Text] [Related]
23. Idarucizumab for Reversal of Dabigatran in Early/Emergency Surgeries: A Case Series.
Peacock WF; Grotta JC; Steiner T
J Emerg Med; 2019 Dec; 57(6):e167-e173. PubMed ID: 31662218
[TBL] [Abstract][Full Text] [Related]
24. Idarucizumab: A Review as a Reversal Agent for Dabigatran.
Syed YY
Am J Cardiovasc Drugs; 2016 Aug; 16(4):297-304. PubMed ID: 27388764
[TBL] [Abstract][Full Text] [Related]
25. Idarucizumab Improves Outcome in Murine Brain Hemorrhage Related to Dabigatran.
Na SY; Mracsko E; van Ryn J; Veltkamp R
Ann Neurol; 2015 Jul; 78(1):137-41. PubMed ID: 25899749
[TBL] [Abstract][Full Text] [Related]
26. Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study.
Glund S; Stangier J; van Ryn J; Schmohl M; Moschetti V; Haazen W; De Smet M; Gansser D; Norris S; Lang B; Reilly P; Kreuzer J
Clin Pharmacokinet; 2017 Jan; 56(1):41-54. PubMed ID: 27317414
[TBL] [Abstract][Full Text] [Related]
27. Reversal of dabigatran by idarucizumab: when and how?
Vanassche T; Greinacher A; Verhamme P
Expert Rev Hematol; 2016 Jun; 9(6):519-28. PubMed ID: 27166653
[TBL] [Abstract][Full Text] [Related]
28. Idarucizumab for dabigatran overdose.
Peetermans M; Pollack C; Reilly P; Liesenborghs L; Jacquemin M; Levy JH; Weitz JI; Verhamme P
Clin Toxicol (Phila); 2016 Sep; 54(8):644-6. PubMed ID: 27224445
[TBL] [Abstract][Full Text] [Related]
29. Whole Blood Point-of-Care Testing for Incomplete Reversal With Idarucizumab in Supratherapeutic Dabigatran.
Takeshita S; Tanaka KA; Sawa T; Sanda M; Mizobe T; Ogawa S
Anesth Analg; 2020 Feb; 130(2):535-541. PubMed ID: 31490820
[TBL] [Abstract][Full Text] [Related]
30. Incomplete dabigatran reversal with idarucizumab.
Steele AP; Lee JA; Dager WE
Clin Toxicol (Phila); 2018 Mar; 56(3):216-218. PubMed ID: 28704111
[TBL] [Abstract][Full Text] [Related]
31. Idarucizumab for Reversing Dabigatran-Induced Anticoagulation: A Systematic Review.
Thibault N; Morrill AM; Willett KC
Am J Ther; 2018; 25(3):e333-e338. PubMed ID: 27175894
[TBL] [Abstract][Full Text] [Related]
32. Cholestatic liver injury as a side-effect of dabigatran and the use of coagulation tests in dabigatran intoxication and after reversal by idarucizumab in bleeding and sepsis.
Comuth WJ; Haase AM; Henriksen LØ; Malczynski J; van de Kerkhof D; Münster AB
Scand J Clin Lab Invest; 2018; 78(1-2):1-5. PubMed ID: 29148292
[TBL] [Abstract][Full Text] [Related]
33. Evidence supporting idarucizumab for the reversal of dabigatran.
Pollack CV
Am J Emerg Med; 2016 Nov; 34(11S):33-38. PubMed ID: 27697436
[TBL] [Abstract][Full Text] [Related]
34. Performance of idarucizumab as antidote of dabigatran in daily clinical practice.
van der Wall SJ; van Rein N; van den Bemt B; Kruip MJHA; Meijer K; Te Boome LCJ; Simmers TA; Alings AMW; Tieleman R; Klok FA; Huisman MV; Westerweel PE
Europace; 2019 Mar; 21(3):414-420. PubMed ID: 30339226
[TBL] [Abstract][Full Text] [Related]
35. Idarucizumab, a Humanized, Monoclonal Antibody Fragment for Immediate Reversal of Dabigatran.
Miyares MA; Kuyumjian Y; Eaves S; Dollard E
J Pharm Pract; 2015 Dec; 28(6):548-54. PubMed ID: 26894245
[TBL] [Abstract][Full Text] [Related]
36. Real-World Experience with Idarucizumab to Reverse Anticoagulant Effect in Dabigatran-Treated Patients: Report of 11 Cases from Taiwan.
Tsai LK; Lin HJ; Chua SK; Liao PC; Yang YP; Chou PC; Lee CW; Lin MJ; Chen HM; Yeh JT; Li YH
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):e27-e33. PubMed ID: 29122465
[TBL] [Abstract][Full Text] [Related]
37. [Administration of idarucizumab in spontaneous intracerebral hemorrhage under dabigatran-therapy].
Bereczki D; Szilágyi G; Kakuk I; Szakács Z; May Z
Ideggyogy Sz; 2017 Sep; 70(9-10):349-353. PubMed ID: 29870627
[TBL] [Abstract][Full Text] [Related]
38. Idarucizumab for Reversal of Dabigatran-Associated Bleeding: Misnomer or Miracle?
Miller L; Ferreira JA; Tucker C
J Emerg Med; 2017 Mar; 52(3):341-347. PubMed ID: 27727040
[TBL] [Abstract][Full Text] [Related]
39. Prothrombin Complex Concentrate Is Effective in Treating the Anticoagulant Effects of Dabigatran in a Porcine Polytrauma Model.
Honickel M; Braunschweig T; van Ryn J; Ten Cate H; Spronk HM; Rossaint R; Grottke O
Anesthesiology; 2015 Dec; 123(6):1350-61. PubMed ID: 26414500
[TBL] [Abstract][Full Text] [Related]
40. idarucizumab (PRAXBIND°). Don't rely too heavily on this dabigatran antidote.
Prescrire Int; 2016 Nov; 25(176):260-263. PubMed ID: 30715821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]